N+1 Singer | Institutional Broker and Corporate Advisor

August 15, 2017

APQ: successful raise of £20.09 million on the International Securities Market

APQ has successfully raised £20.09 million through a placing of convertible unsecured loan stock 2024 (“CULS”) on the International Securities Market, the London Stock Exchange’s market for fixed income securities, to expand its portfolio...

August 1, 2017

N+1 Singer ranked number 1 adviser to AIM Consumer Goods Clients

Published quarterly, the AIM Advisers Rankings Guide ranks the top 20 auditors, financial advisers, financial PRs, law firms, registrars and stockbrokers by client numbers and their market cap. In the stockbroker category, N+1 Singer is...

July 26, 2017

ReNeuron: Appointment of N+1 Singer as Joint Broker

ReNeuron Group plc (the "Company") (AIM: RENE), a leading UK-based stem cell therapy development company has announced the appointment of Nplus1 Singer Advisory LLP ('N+1 Singer') as its joint broker with immediate effect.

This year, N+1 Singer celebrates 10 years of raising equity for the growth of the UK's small and mid-cap sector.

We are a partnership and as such can take a long-term view to deliver our clients strategies.

We have advised on more than 115 IPOs, secondary offerings and block trades, raising £2.3bn for 72 companies since 2013.

Technology

Life Sciences

Technology

Technology

Consumer

Chemicals

Financials

Investment Funds

Investment Funds

Technology

Support Services

Capital Goods

Consumer

Life Sciences

Investment Funds

Technology

Support Services

Retail

Investment Funds

Life Sciences

Financials

Consumer

Technology

Life Sciences

Financials

Technology

Support Services

Technology

Technology

Investment Funds

Life Sciences

Chemicals

Life Sciences

Capital Goods

Retail

Technology

Life Sciences

Media

Media

Support Services

Technology

Investment Funds

Financials

Support Services

Financials

Investment Funds

Technology

Technology

Investment Funds

Life Sciences

Chemicals

Support Services

Technology

Media

Financials

Technology

Support Services

Retail

Consumer

Investment Funds

Technology

Life Sciences

Technology

Media

Investment Funds

Life Sciences

Investment Funds

Life Sciences

Financials

Investment Funds

Technology

Technology

Investment Funds

Capital Goods

Life Sciences

Retail

Support Services

Technology

Life Sciences

Financials

Support Services

Support Services

Investment Funds

Support Services

Capital Goods

Investment Funds

Media

Capital Goods